Cetera Investment Advisers
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1666741
SCHAUMBURG, IL
Position in REGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$9,143,590
-$3,223,285 QoQ
Shares Held
14,664
-8.4% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#308
of 1,322 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Mar 31, 2026CallValue
$5,960
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $187,106,390 across 112 Biotechnology names. REGN ranks #4 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
78,107 | $38,798,090 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
1,140,476 | $9,984,867 | |
| 3 | EXEL |
Exelixis, Inc.
|
169,657 | $9,231,037 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
14,664 | $9,143,590 | |
| 5 | OCUL |
Ocular Therapeutix, Inc
|
785,732 | $7,715,888 | |
| 6 | ARGX |
Argenx SE
|
7,844 | $7,277,427 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
184,543 | $7,199,022 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,196 | $6,982,691 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,143,590 | 14,664 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,960 | 100 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $12,366,875 | 16,006 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $12,201,720 | 15,808 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,023,871 | 16,049 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,120,850 | 9,754 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $6,706,982 | 10,575 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $6,581,216 | 9,239 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,193,093 | 8,745 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $8,351,484 | 7,946 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $9,387,164 | 9,753 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $3,335,745 | 3,798 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,028,492 | 3,680 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,726,140 | 3,794 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,043,465 | 3,704 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,305,160 | 3,195 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $980,950 | 1,424 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,619,105 | 2,739 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,109,926 | 3,021 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,946,976 | 3,083 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,587,992 | 2,624 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,435,447 | 2,570 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,305,393 | 2,759 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,099,558 | 2,276 | Shares | Sole | 2021-02-17 | |
| No filing history on record for this holder in this stock. | ||||||